Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.


8 01, 2015

If this works out a lot of us may live longer…

Tags: , , , , , , |0 Comments

Our next, best shot: immunotherapy agents that attack CD38 proteins on the cell walls of multiple myeloma cells: Anti-CD38 antibodies poised to transform myeloma treatment By: PATRICE WENDLING, Oncology Practice Digital Network Jan 5, 2015 Vitals Key clinical point: The investigational anti-CD38 antibodies SAR650984 and daratumumab in combination with standard regimens were highly active in

1 07, 2013

More about MOR202

Tags: , , , |1 Comment

Yesterday's post generated quite a bit of interest.  Here's what I know about CD38 and MOR202  In January 2012, a 19 year old company that specializes in human antibody research, MorphoSys, received a U.S. patent for MOR202, a fully human HuCAL antibody.  This new antibody was designed to use CD38 as a therapeutic target for

3 12, 2010

Experimental Anti-Body, MOR202, To Be Featured In New Phase One Study Next Year

Tags: , , , , |0 Comments

Hello from cold (for Florida) sunny Orlando!  ASH starts later today, but I'm getting an early start.  Still plenty to learn and share. For those of you who just can't get enough multiple myeloma related technical information, here is a link to a power point presentation about an experimental anti-myeloma anti-body, MOR202.Lots of photos, charts and graphs.